InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,446.00
(
2.17%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
82.77
(
0.00%
)
Bitcoin
63,729.07
(
-0.26%
)
Post# of 615
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

~ TRT ~

Send PM Follow Ignore
Followers 461
Posts 25261
Boards Moderated 0
Alias Born 06/26/2006

~ TRT ~

Re: None

Saturday, 05/02/2009 3:27:05 PM

Saturday, May 02, 2009 3:27:05 PM

Post# of 615
Post from another board... CSAR Q109 was much imporved than Q108.

Q1 was actually much improved quarter than Q1 last year. Even though revenue dropped to $159M from $216M, gross margin improved to 16% vs 11% in Q108. Operating income increased 30% to $4.8M from $3.6M. The loss was due to impairment and restructuring cost - which are heading to zero in two more quarters. So without impairment and restructure cost, EBITDA = $4.8M.

Credit facility extension agreement is reached. senior notes extension are very likely to come this month. CSAR should move north next week.

All posts are only my opinion and are not buy or sell recommendation.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up